A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem
Advanced Science · 2024-10 · 11 (40)
DOI: 10.1002/advs.202405640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 29.08.2024. Verfasst von Fang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Center, Beijing Chest Hospital, Capital Medical University, 9 Beiguan Street, Beijing, 101149, China. Hauptthemen laut MEDLINE: Nanoparticles, Photochemotherapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Administration of Hospitals' Incubating Programme, Beijing Municipal Administration of Hospitals' Youth Programme.
Abstract (Originalsprache)
The lack of precise spatiotemporal gene modulation and therapy impedes progress in medical applications. Herein, a 980 nm near‐infrared (NIR) light‐controlled nanoplatform, namely URMT, is developed, which can allow spatiotemporally controlled photodynamic therapy and trigger the enzyme‐activated gene expression regulation in tumors. URMT is constructed by engineering an enzyme‐activatable antisense oligonucleotide, which combined with an upconversion nanoparticle (UCNP)‐based photodynamic nanosystem, followed by the surface functionalization of triphenylphosphine (TPP), a mitochondria‐targeting ligand. URMT allows for the 980 nm NIR light‐activated generation of reactive oxygen species, which can induce the translocation of a DNA repair enzyme (namely apurinic/apyrimidinic endonuclease 1, APE1) from the nucleus to mitochondria. APE1 can recognize the basic apurinic/apyrimidinic (AP) sites in DNA double‐strands and perform cleavage, thereby releasing the functional single‐strands for gene regulation. Overall, an augmented antitumor effect is observed due to NIR light‐controlled mitochondrial damage and enzyme‐activated gene regulation. Altogether, the approach reported in this study offers high spatiotemporal precision and shows the potential to achieve precise and specific gene regulation for targeted tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Medicine Center, Beijing Chest Hospital, Capital Medical University, 9 Beiguan Street, Beijing, 101149, China.
- College of Science, Minzu University of China, 27 Zhongguancun South Avenue, Beijing, 100081, China.
ORCID-Profile: Hongqian Chu
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Administration of Hospitals' Incubating Programme
- Beijing Municipal Administration of Hospitals' Youth Programme
Zitieren
APA
Wang, F., Liu, Z., Liu, Y., Zhang, J., Xu, W., Liu, B., Sun, Z., & Chu, H. (2024). A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem. Advanced Science, 11(40). https://doi.org/10.1002/advs.202405640
Vancouver
Wang F, Liu Z, Liu Y, Zhang J, Xu W, Liu B, et al. A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem. Advanced Science. 2024;11(40). doi:10.1002/advs.202405640
BibTeX
@article{Wang2024,
author = {Wang, Fang and Liu, Zechao and Liu, Yuechen and Zhang, Jiayi and Xu, Weizhe and Liu, Bei and Sun, Zhaogang and Chu, Hongqian},
title = {A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {40},
doi = {10.1002/advs.202405640}
}
EUVIMED